OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antitumor Peptide-Based Vaccine in the Limelight
Takumi Kumai, Hidekiyo Yamaki, Michihisa Kono, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 70-70
Open Access | Times Cited: 14

Showing 14 citing articles:

Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs
Amit Lath, Anita Rani Santal, Nameet Kaur, et al.
Biotechnology and Genetic Engineering Reviews (2022) Vol. 39, Iss. 1, pp. 45-84
Closed Access | Times Cited: 46

The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise
Jizhong Che, Yuanyuan Liu, Yangyang Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Cancer Vaccines: From the State of the Art to the Most Promising Frontiers in the Treatment of Colorectal Cancer
Eleonora Martinis, Carolina Ricci, Caterina Trevisan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1969-1969
Open Access | Times Cited: 12

Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers
Ryosuke Sato, Hidekiyo Yamaki, Hiroki Komatsuda, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1205-1205
Open Access | Times Cited: 4

Progress and Challenges of Messenger RNA Vaccines in the Therapeutics of NSCLC
Eftychia Kiousi, Vasiliki Lyraraki, Georgia Lamprini Mardiki, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5589-5589
Open Access | Times Cited: 9

Translational research in head and neck cancer: Molecular and immunological updates
Takumi Kumai, Hirotaka Shinomiya, Hirofumi Shibata, et al.
Auris Nasus Larynx (2023) Vol. 51, Iss. 2, pp. 391-400
Closed Access | Times Cited: 6

Immunogenicity of peptide‐based vaccine composed of epitopes from Echinococcus granulosus rEg.P29
Yongxue Lv, Liangliang Chang, Jihui Yang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 4
Open Access | Times Cited: 5

Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer
Hidekiyo Yamaki, Michihisa Kono, Risa Wakisaka, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 8, pp. 2799-2812
Open Access | Times Cited: 5

Reduced T Cell Priming in Microbially Experienced “Dirty” Mice Results from Limited IL-27 Production by XCR1+ Dendritic Cells
Frances V. Sjaastad, Matthew A. Huggins, Erin D. Lucas, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 11, pp. 2149-2159
Open Access | Times Cited: 6

Novel Therapies for Colorectal Cancers
Muriel Battaglia, Susan Feldt, Marcus Marable, et al.
IntechOpen eBooks (2024)
Closed Access

Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer
Hidekiyo Yamaki, Michihisa Kono, Risa Wakisaka, et al.
Research Square (Research Square) (2023)
Open Access

Harnessing Immunity to Treat Advanced Thyroid Cancer
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 45-45
Open Access

Page 1

Scroll to top